COMPARATIVE STUDY OF EXPRESSION OF ADAPTOR PROTEINS RUK/CIN85 AND CD2AP/CMS IN NORMAL AND TUMOR HUMAN UTERUS TISSUES

O. I. Basaraba, Ya. P. Bobak, H. Yu. Shuvayeva, O. M. Mayevska, N. I. Igumentseva, S. M. Marchenko, N. A. Volodko, V. L. Buchman, L. B. Drobot


DOI: http://dx.doi.org/10.30970/sbi.0303.054

Abstract


Adaptor proteins play an important role in facilitating protein-protein interactions and subsequent formation of signalling networks. These proteins recruit binding partners to a specific location inside the cell, and also regulate their activity. Adaptor protein Ruk/CIN85 and its structural and functional homologue CD2AP/CMS are important components of different regulatory pathways involved in control of cell proliferation, adhesion, invasion and survival, and, thus, can play a role in uterine carcinogenesis. In this work, we set out a comparative study of expression of Ruk/CIN85 and CD2AP/CMS at the level of mRNA and protein in intact uterine tissues, as well as in benign and malignant uterine tumors of different histological types. In most cases, an increase of expression levels of Ruk/CIN85 full-length form mRNA and protein, as well as CD2AP/CMS protein, were observed in uterine tumors, comparing with surrounding normal uterine tissues. Characteristic feature of conditionally normal uterine tissues, as well as benign uterine lesions, was an elevated content of high-molecular mass Ruk/CIN85 forms of 140 and 130 kDa, while an increased expression level of low-molecular mass 40 and 30 kDa Ruk/CIN85 forms was observed in the malignant tissue samples. Our findings suggest that an abnormal expression patterns of adaptor proteins Ruk/CIN85 and CD2AP/CMS in uterine tumors, and, thus, the corresponding changes in the activity of downstream signalling pathways, might be involved in maintenance of the malignant phenotype.


Keywords


tumorigenesis, adaptor proteins, Ruk/CIN85, CD2AP/CMS, benign and malignant uterine tumors

Full Text:

PDF

References


1. Aissouni Y., Zapart G., Iovanna J.L. et al. CIN85 regulates the ability of MEKK4 to activate the p38 MAP kinase pathway. BBRC, 2005; 338: 808-814.
https://doi.org/10.1016/j.bbrc.2005.10.032
PMid:16256071

2. Borthwick E., Korobko I., Luke C. et al. Multiple Domains of Ruk/CIN85/SETA/CD2BP3 are involved in interaction with p85a regulatory subunit of PI 3-kinase. J. Mol. Biol, 2004; 343: 1135-1146.
https://doi.org/10.1016/j.jmb.2004.08.075
PMid:15476827

3. Buchman V., Luke C., Borthwick E. et al. Organization of the mouse Ruk locus and expression of isoforms in mouse tissues. Gene, 2002; 295: 13-17.
https://doi.org/10.1016/S0378-1119(02)00821-1

4. Castellvi J., Garcia A., Ruiz-Marcellan C. et al. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis. Hum. Pathol, 2009; 40(10): 1418-1426.
https://doi.org/10.1016/j.humpath.2008.12.019
PMid:19428047

5. Chen B., Borinstein S.C., Gillis J. et al. The glioma-associated protein SETA interacts with AIP1/Alix and ALG-2 and modulates apoptosis in astrocytes. J. Biol. Chem, 2000; 275: 19275-19281.
https://doi.org/10.1074/jbc.M908994199
PMid:10858458

6. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques, 1993; 15: 532-4, 536-7.

7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem, 1987; 162(1): 156-159.
https://doi.org/10.1016/0003-2697(87)90021-2

8. Dikic I. CIN85/CMS family of adaptor molecules. FEBS Lett, 2002; 529: 110-115.
https://doi.org/10.1016/S0014-5793(02)03188-5

9. Dikic I., Giordano S. Negative receptor signalling. Curr. Opin. Cell Biol, 2003; 15: 128-135.
https://doi.org/10.1016/S0955-0674(03)00004-8

10. Dustin M.L., Olszowy M.W., Holdorf A.D. et al. A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell, 1998; 94(5): 667-677.
https://doi.org/10.1016/S0092-8674(00)81608-6

11. Ejskjaer K., Sørensen B.S., Poulsen S.S. et al. Expression of the epidermal growth factor system in endometrioid endometrial cancer. Gynecol. Oncol, 2007; 104(1): 158-167.
https://doi.org/10.1016/j.ygyno.2006.07.015
PMid:16962163

12. Flynn D.C. Adaptor protein. Oncogene, 2001; 20: 6270-6272.
https://doi.org/10.1038/sj.onc.1204769
PMid:11607828

13. Gabriel B., zur Hausen A., Stickeler E. et al. Weak expression of focal adhesion kinase (pp125FAK) in patients with cervical cancer is associated with poor disease outcome. Clin. Cancer Res, 2006;12(8): 2476-2483.
https://doi.org/10.1158/1078-0432.CCR-05-1867
PMid:16638855

14. Gaidos G., Soni S., Oswald D.J. et al. Structure and function analysis of the CMS/CIN85 protein family identifies actin-bundling properties and heterotypic-complex formation. J. Cell Sci, 2007; 120(14): 2366-2377.
https://doi.org/10.1242/jcs.004333
PMid:17606992

15. Gout I., Middleton G., Adu J. et al. Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein. EMBO J, 2000; 19(15): 4015-4025.
https://doi.org/10.1093/emboj/19.15.4015
PMid:10921882 PMCid:PMC306608

16. Johnson R.I., Seppa M.J., Cagan R.L. The Drosophila CD2AP/CIN85 orthologue Cindr regulates junctions and cytoskeleton dynamics during tissue patterning. J. Cell Biol, 2008; 80(6): 1191-1204.
https://doi.org/10.1083/jcb.200706108
PMid:18362180 PMCid:PMC2290846

17. Kirsch K., Georgescu M., Ishimaru S., Hanafusa H. CMS: an adapter molecule involved in cytoskeletal rearrangements. Proc. Natl. Acad. Sci. USA, 1999; 96(11): 6211-6216.
https://doi.org/10.1073/pnas.96.11.6211
PMid:10339567 PMCid:PMC26861

18. Kowanetz K., Husnjak K., Höller D. et al. CIN85 Associates with Multiple Effectors Controlling Intracellular Trafficking of Epidermal Growth Factor Receptors. J. Mol. Biol, 2004; 15: 3155-3166.
https://doi.org/10.1091/mbc.e03-09-0683
PMid:15090612 PMCid:PMC452573

19. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970; 227: 680-684.
https://doi.org/10.1038/227680a0
PMid:5432063

20. Lee K.H., Dinner A.R., Tu C. et al. The Immunological Synapse Balances T Cell Receptor Signalling and Degradation. Science, 2003; 302: 1218-1222.
https://doi.org/10.1126/science.1086507
PMid:14512504

21. Liang Y., Kurakin A., Roizman B. Herpes simplex virus 1 infected cell protein 0 forms a complex with CIN85 and Cbl and mediates the degradation of EGF receptor from cell surfaces. Proc. Natl. Acad. Sci. USA, 2005; 102: 5838-5843.
https://doi.org/10.1073/pnas.0501253102
PMid:15824310 PMCid:PMC556299

22. Mayevska O., Shuvayeva H., Igumentseva N. et al. Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma. Exp. Oncol, 2006; 28: 275-281.

23. Monzo P., Gauthier N.C., Keslair F. et al. Clues to CD2-associated protein involvement in cytokinesis. Mol. Biol. Cell, 2005; 16(6): 2891-2902.
https://doi.org/10.1091/mbc.e04-09-0773
PMid:15800069 PMCid:PMC1142433

24. Mori N., Kyo S., Sakaguchi J. et al. Concomitant activation of AKT with extracellular-regulated kinase 1/2 occurs independently of PTEN or PIK3CA mutations in endometrial cancer and may be associated with favorable prognosiss. Cancer Sci, 2007; 98(12): 1881-1888.
https://doi.org/10.1111/j.1349-7006.2007.00630.x
PMid:17924977

25. Nam J.M., Onodera Y., Mazaki Y. et al. CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery. EMBO J, 2007; 26(3): 647-656.
https://doi.org/10.1038/sj.emboj.7601534
PMid:17255943 PMCid:PMC1794391

26. Narita T., Nishimura T., Yoshizaki K., Taniyama T. CIN85 associates with TNF receptor 1 via Src and modulates TNF-a-induced apoptosis. Exp. Cell Res, 2005; 304: 256-264.
https://doi.org/10.1016/j.yexcr.2004.11.005
PMid:15707590

27. Petrelli A., Gilestro G.F., Lanzardo S. et al. The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature, 2002; 416: 187-190.
https://doi.org/10.1038/416187a
PMid:11894096

28. Sakakibara T., Nemoto Y., Nukiwa T., Takeshima H. Identification and characterization of a novel Rho GTPase activating protein implicated in receptor-mediated endocytosis. FEBS Lett, 2004; 566: 294-300.
https://doi.org/10.1016/j.febslet.2004.03.101
PMid:15147912

29. Schiffer M., Mundel P., Shaw A.S., Böttinger E.P. A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis. J. Biol. Chem, 2004; 279(35): 37004-37012.
https://doi.org/10.1074/jbc.M403534200
PMid:15213232

30. Schmidt M., Chen B., Randazzo L., Bogler O. SETA/CIN85/Ruk and its binding partner AIP1 associate with diverse cytoskeletal elements, including FAKs, and modulate cell adhesion. J. Cell Sci, 2003; 116: 2845-2855.
https://doi.org/10.1242/jcs.00522
PMid:12771190

31. Schwartz L.A. Cervical cancer: disease prevention and informational support. Can. Oncol. Nurs. J, 2009; 19(1): 6-9.
https://doi.org/10.5737/1181912x19169
PMid:19530473

32. Soubeyran P., Kowanetz K., Szymkiewicz I. et al. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature, 2002; 416(14): 183-186.
https://doi.org/10.1038/416183a
PMid:11894095

33. Tibaldi E., Reinherz E. CD2BP3, CIN85 and the structurally related adaptor protein CMS bind to the same CD2 cytoplasmic segment, but elicit divergent functional activities. Int. Immunol, 2003; 15(3): 313-329.
https://doi.org/10.1093/intimm/dxg032
PMid:12618476

34. Tossidou I., Kardinal Ch., Peters I. et al. CD2AP/CIN85 Balance Determines Receptor Tyrosine Kinase Signalling Response in Podocytes. J. Biol. Chem, 2007; 282: 7457-7464.
https://doi.org/10.1074/jbc.M608519200
PMid:17213204

35. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA, 1979; 76: 4350-4354.
https://doi.org/10.1073/pnas.76.9.4350
PMid:388439 PMCid:PMC411572

36. Verdier F., Valovka T., Zhyvoloup A. et al. Ruk is ubiquitinated but not degraded by the proteasome. Eur. J. Biochem, 2002; 269(14): 3402-3408.
https://doi.org/10.1046/j.1432-1033.2002.03031.x
PMid:12135478

37. Yuan H., Takeuchi E., Salant D.J. Podocyte slit-diaphragm protein nephrin is linked to the actin cytoskeleton. Am. J. Physiol. Renal. Physiol, 2002; 282(4): 585-591.
https://doi.org/10.1152/ajprenal.00290.2001
PMid:11880318

38. Zhang X.Y., Zhang H.Y., Zhang P.N. et al. Elevated phosphatidylinositol 3-kinase activation and its clinicopathological significance in cervical cancer. Eur. J. Obstet. Gynecol. Reprod. Biol, 2008; 139(2): 237-244.
https://doi.org/10.1016/j.ejogrb.2007.12.021
PMid:18395956


Refbacks

  • There are currently no refbacks.


Copyright (c) 2009 Studia biologica

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.